【制药网 行业动态】根据梳理,6月23日~6月29日,至少有5家致力于创新药研发的新锐公司宣布完成新一轮融资,包括药捷安康、华卫恒源等。其中药捷安康(南京)科技股份有限公司(以下简称“药捷安康”)6月23日成功于香港联交所主板挂牌上市。此次药捷安康全球发售以每股13.15港元定价,共发行15,281,000股,募集资金金额达2.01亿港元。资料显示,药捷安康是一家以临床需求为导向、处于注册临床阶段...
Source Link【制药网 行业动态】根据梳理,6月23日~6月29日,至少有5家致力于创新药研发的新锐公司宣布完成新一轮融资,包括药捷安康、华卫恒源等。其中药捷安康(南京)科技股份有限公司(以下简称“药捷安康”)6月23日成功于香港联交所主板挂牌上市。此次药捷安康全球发售以每股13.15港元定价,共发行15,281,000股,募集资金金额达2.01亿港元。资料显示,药捷安康是一家以临床需求为导向、处于注册临床阶段...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.